FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

108515008: Diclofenac potassium (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
173049016 Diclofenac potassium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
601623015 Diclofenac potassium (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
805641000172112 diclofénac potassique fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Diclofenac potassium Is a Diclofenac false Inferred relationship Some
Diclofenac potassium Is a Heteroaryl acetic acid (substance) true Inferred relationship Some
Diclofenac potassium Is a Non-steroidal anti-inflammatory agent (substance) true Inferred relationship Some
Diclofenac potassium This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Diclofenac true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Diclofenac potassium 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Diclofenac potassium Inferred relationship Some
Diclofenac potassium 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Diclofenac potassium Inferred relationship Some
Product containing diclofenac potassium The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Diclofenac potassium Inferred relationship Some
Diclofenac potassium 50 mg powder for oral solution sachet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Diclofenac potassium Inferred relationship Some
Diclofenac potassium 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Diclofenac potassium Inferred relationship Some 1
Diclofenac potassium 25 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Diclofenac potassium Inferred relationship Some 1
Diclofenac potassium 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Diclofenac potassium Inferred relationship Some 1
Diclofenac potassium 50 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Diclofenac potassium Inferred relationship Some 1
Diclofenac potassium 50 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Diclofenac potassium Inferred relationship Some 1
Diclofenac potassium 25 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Diclofenac potassium Inferred relationship Some 1
Diclofenac potassium 50 mg powder for oral solution sachet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Diclofenac potassium Inferred relationship Some 1
Diclofenac potassium 50 mg powder for oral solution sachet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Diclofenac potassium Inferred relationship Some 1
Product containing precisely chlorzoxazone 500 milligram and diclofenac potassium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Diclofenac potassium Inferred relationship Some 1
Product containing precisely chlorzoxazone 500 milligram and diclofenac potassium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Diclofenac potassium Inferred relationship Some 1
Diclofenac potassium 50 mg and paracetamol 325 mg and serrapeptase 10 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Diclofenac potassium Inferred relationship Some 2
Diclofenac potassium 50 mg and paracetamol 325 mg and serrapeptase 10 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Diclofenac potassium Inferred relationship Some 2
Product containing precisely diclofenac potassium 50 milligram and paracetamol 325 milligram and serrapeptase 15 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Diclofenac potassium Inferred relationship Some 2
Product containing precisely diclofenac potassium 50 milligram and paracetamol 325 milligram and serrapeptase 15 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Diclofenac potassium Inferred relationship Some 2

This concept is not in any reference sets

Back to Start